Aarkstore - Hepatitis A - Pipeline Review, H1 2014

1
Aarkstore - Hepatitis A - Pipeline Review, H1 2014
www.aarkstore.com
2
Summary

• Hepatitis A - Pipeline Review, H1 2014,
  provides an overview of the Hepatitis As
• therapeutic pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Hepatitis A, complete with
  comparative analysis at various stages,
• therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration
• (RoA) and molecule type, along with latest
  updates, and featured news and press releases. It
• also reviews key players involved in the
  therapeutic development for Hepatitis A and
  special
• features on late-stage and discontinued projects.

www.aarkstore.com
www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Hepatitis A- The
  report reviews key pipeline products under drug
  profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities - The report reviews key players
  involved in the therapeutics development for
  Hepatitis A and enlists all their major and minor
  projects- The report summarizes all the dormant
  and discontinued pipeline projects - A review of
  the Hepatitis A products under development by
  companies and universities/research institutes
  based on information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects- Coverage of the Hepatitis A pipeline
  on the basis of target, MoA, route of
  administration and molecule type

www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Acute Heart Failure- Plan mergers and
  acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Acute Heart Failure pipeline depth
  and focus of Indication therapeutics- Develop
  and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope

www.aarkstore.com
5
Table of Contents

• IntroductionREPORT COVERAGEHepatitis A
  OverviewTherapeutics DevelopmentPipeline
  Products for Hepatitis A - OverviewPipeline
  Products for Hepatitis A - Comparative
  AnalysisHepatitis A - Therapeutics under
  Development by CompaniesHepatitis A -
  Therapeutics under Investigation by
  Universities/InstitutesHepatitis A - Pipeline
  Products GlanceLate Stage ProductsEarly Stage
  ProductsUnknown Stage Products

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Hepatitis A, H1 2014Number of Products under
  Development for Hepatitis A - Comparative
  Analysis, H1 2014Number of Products under
  Development by Companies, H1 2014Number of
  Products under Investigation by
  Universities/Institutes, H1 2014Comparative
  Analysis by Late Stage Development, H1
  2014Comparative Analysis by Early Stage
  Development, H1 2014Comparative Analysis by
  Unknown Stage Development, H1 2014Products under
  Development by Companies, H1 2014Products under
  Investigation by Universities/Institutes, H1
  2014Hepatitis A - Pipeline by iQur Ltd., H1 2014

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Hepatitis A, H1 2014Number of Products under
  Development for Hepatitis A - Comparative
  Analysis, H1 2014Number of Products under
  Development by Companies, H1 2014Comparative
  Analysis by Early Stage Products, H1
  2014Assessment by Monotherapy Products, H1
  2014Number of Products by Top 10 Molecule Type,
  H1 2014Number of Products by Stage and Top 10
  Molecule Type, H1 2014 22

www.aarkstore.com
8
Related Market Research reports

• Corticosteroid-Responsive Dermatoses - Pipeline
  Review, H1 2014
• Hematological Tumor - Pipeline Review, H1 2014
• Inflammation - Pipeline Review, H1 2014
• Opioid Induced Side Effects - Pipeline Review, H1
  2014
• Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports

• Restenosis - Pipeline Review, H1 2014
• Tauopathies - Pipeline Review, H1 2014
• Nasopharyngitis (Common Cold) - Pipeline Review,
  H1 2014
• Mucopolysaccharidosis III (MPS III) (Sanfilippo
  Syndrome) - Pipeline Review, H1 2014
• Chemotherapy Induced Peripheral Neuropathy -
  Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Hepatitis A - Pipeline Review, H1 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com